ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma (07-REV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00847639
Recruitment Status : Completed
First Posted : February 19, 2009
Last Update Posted : April 4, 2014
Sponsor:
Collaborators:
National Marrow Donor Program
Celgene Corporation
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : March 2014